These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37983186)

  • 1. Synthesis of Anticoagulant Pentasaccharide Fondaparinux via 3,5-Dimethyl-4-(2'-phenylethynylphenyl)phenyl Glycosides.
    Liu W; Hu Z; Xu P; Yu B
    Org Lett; 2023 Dec; 25(47):8506-8510. PubMed ID: 37983186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total synthesis of anticoagulant pentasaccharide fondaparinux.
    Li T; Ye H; Cao X; Wang J; Liu Y; Zhou L; Liu Q; Wang W; Shen J; Zhao W; Wang P
    ChemMedChem; 2014 May; 9(5):1071-80. PubMed ID: 24729477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of the heparin-based anticoagulant drug fondaparinux.
    Chang CH; Lico LS; Huang TY; Lin SY; Chang CL; Arco SD; Hung SC
    Angew Chem Int Ed Engl; 2014 Sep; 53(37):9876-9. PubMed ID: 25044485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosylation with 3,5-Dimethyl-4-(2'-phenylethynylphenyl)phenyl (EPP) Glycosides via a Dearomative Activation Mechanism.
    Hu Z; Tang Y; Yu B
    J Am Chem Soc; 2019 Mar; 141(12):4806-4810. PubMed ID: 30864790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical synthesis and pharmacological properties of heparin pentasaccharide analogues.
    Zhou Z; Zhang L; Wu X; Luo L; Wu J; Xu D; Wu M
    Eur J Med Chem; 2022 Apr; 234():114256. PubMed ID: 35279609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of Fondaparinux: modular synthesis investigation for heparin synthesis.
    Lin F; Lian G; Zhou Y
    Carbohydr Res; 2013 Apr; 371():32-9. PubMed ID: 23474455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Programmable One-Pot Synthesis of Heparin Pentasaccharide Fondaparinux.
    Dey S; Lo HJ; Wong CH
    Org Lett; 2020 Jun; 22(12):4638-4642. PubMed ID: 32496799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia.
    Schindewolf M; Steindl J; Beyer-Westendorf J; Schellong S; Dohmen PM; Brachmann J; Madlener K; Pötzsch B; Klamroth R; Hankowitz J; Banik N; Eberle S; Müller MM; Kropff S; Lindhoff-Last E
    J Am Coll Cardiol; 2017 Nov; 70(21):2636-2648. PubMed ID: 29169470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a recombinant antithrombin variant as a potent antidote to fondaparinux and other heparin derivatives.
    Bianchini EP; Fazavana J; Picard V; Borgel D
    Blood; 2011 Feb; 117(6):2054-60. PubMed ID: 21048158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formal Synthesis of Anticoagulant Drug Fondaparinux Sodium.
    Dai X; Liu W; Zhou Q; Cheng C; Yang C; Wang S; Zhang M; Tang P; Song H; Zhang D; Qin Y
    J Org Chem; 2016 Jan; 81(1):162-84. PubMed ID: 26650028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient and practical synthesis of Fondaparinux.
    Ding Y; Vara Prasad CVNS; Bai H; Wang B
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2424-2427. PubMed ID: 28408227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the pentasaccharide fondaparinux as an anticoagulant during haemodialysis.
    Kalicki RM; Aregger F; Alberio L; Lämmle B; Frey FJ; Uehlinger DE
    Thromb Haemost; 2007 Dec; 98(6):1200-7. PubMed ID: 18064314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silver-assisted gold-catalyzed formal synthesis of the anticoagulant Fondaparinux pentasaccharide.
    Walke G; Kasdekar N; Sutar Y; Hotha S
    Commun Chem; 2021 Feb; 4(1):15. PubMed ID: 36697540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fondaparinux (Arixtra): a new anticoagulant.
    Giangrande PL
    Int J Clin Pract; 2002 Oct; 56(8):615-7. PubMed ID: 12425373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended Physicochemical Characterization of the Synthetic Anticoagulant Pentasaccharide Fondaparinux Sodium by Quantitative NMR and Single Crystal X-ray Analysis.
    Wildt W; Kooijman H; Funke C; Üstün B; Leika A; Lunenburg M; Kaspersen F; Kellenbach E
    Molecules; 2017 Aug; 22(8):. PubMed ID: 28817073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymatic synthesis of glycosaminoglycan heparin.
    Linhardt RJ; Dordick JS; Deangelis PL; Liu J
    Semin Thromb Hemost; 2007 Jul; 33(5):453-65. PubMed ID: 17629842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fondaparinux (Arixtra(R)), a safe alternative for the treatment of patients with heparin-induced thrombocytopenia?
    Badger NO
    J Pharm Pract; 2010 Jun; 23(3):235-8. PubMed ID: 21507819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed-type hypersensitivity skin reactions due to heparins and heparinoids. Tolerance of recombinant hirudins and of the new synthetic anticoagulant fondaparinux.
    Koch P
    Contact Dermatitis; 2003 Dec; 49(6):276-80. PubMed ID: 15025697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fondaparinux: a potential new therapy for HIT.
    Kuo KH; Kovacs MJ
    Hematology; 2005 Aug; 10(4):271-5. PubMed ID: 16085538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-induced thrombocytopenia successfully treated with fondaparinux.
    Seldrum S; Lambert M; Hainaut P
    Acta Clin Belg; 2009; 64(2):144-6. PubMed ID: 19432027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.